3Mir TS, Laux R, Hellwege H H, et al. Plasma coneemtrations of ami- noterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates:Muarked and rapid increase af- ter birth[J]. Pediatrics, 2003,112(4) : 896-899.
4Rutten FH, Hoes AW. Prtype natriuretie peptide assays for detecting heart failure in the elderly: Same value as those in the younger [J]? Int J Cardiol,2008,125(2) :161-165.
6Leibundgut G, Pfisterer M, Brunner-La, et al. Drug Treatment of Chronic Heart Failure in the Elderly [J]. Drugs Aging, 2007,24 (12) :991-1006.
7Pfeffer MA,Swedberg K,Granger CB,et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme[J]. Lancet, 2003,362 (9386) : 759-866.
8Dulin BR, Haas SJ, Abraham WT,et al. Do elderly systolic heart fail- ure patients benefit from beta blockers to the same extent as the non- elderly? Meta-analysis oral2,000 patients in large-scale clinical tri-als[J]. Am J Cardiol, 2005,95 (7) : 896-898.
10Cleland JG,Swedberg K,Follath F,et al. The EuroHeart Failure sur- vey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1 : Patient characteristics and diagnosis [J]. Eur Heart J,2003,24(5) ,442-463.
2Nymo SH,Ueland T,Askevold ET,et al.The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure:results from coronary[J].J Intern Med,2012;271(5):436-43.
3Liu H,Shi H,Yu J,et al.Obesity and chronic kidney disease in patients with chronic heart failure:an insight from the China Heart Survey[J].Clin Exp Nephrol,2011;15(4):522-8.
